Literature DB >> 6973545

Cellular and humoral immunity in subacute sclerosing panencephalitis.

S S Dhib-Jalbut, A M Abdelnoor, F S Haddad.   

Abstract

Cellular and humoral immunity was studied in 26 patients with subacute sclerosing panencephalitis. Results were compared with those of 14 normal controls and 11 patients suffering from other neurological disorders. It was shown that cellular and humoral immune responses are adequate in subacute sclerosing panencephalitis. The persistently elevated levels of serum immunoglobulin G (IgG) and IgA indicated a persistent infection, and their progressive rise in later stages correlated with the progressive nature of the illness. IgG progressively increased with the clinical stage in the cerebrospinal fluid unaccompanied by a corresponding rise in the measles antibody titer. This suggests that antigenic determinants other than those tested play a role in the production of IgG in the cerebrospinal fluid. The progressive increase in the ratio of cerebrospinal fluid to serum IgG with the advance of the disease suggests synthesis of IgG locally in the central nervous system. Elevated measles antibody titer in serum and cerebrospinal fluid is a consistent aid in the diagnosis of subacute sclerosing panencephalitis. It is more specific in cerebrospinal fluid than in serum. Its level did not vary significantly with the clinical stages or duration of illness. Depressed serum complement activity has been detected in some subacute sclerosing panencephalitis patients in whom serum levels of the third and fourth components of the complement were normal.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973545      PMCID: PMC350649          DOI: 10.1128/iai.33.1.34-42.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Serum immunoglobulin levels in normal children and adults in the Lebanese and other Arab Middle Eastern populations.

Authors:  S Y Alami; H C Zurayk; F S Farah
Journal:  J Med Liban       Date:  1980

2.  Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis.

Authors:  G Barbanti-Brodano; S Oyanagi; M Katz; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

3.  Immunopathologic observations in subacute sclerosing panencephalitis.

Authors:  O Kolar
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

4.  Additional evidence of the relation between subacute inclusion-body encephalitis and measles virus.

Authors:  J M Freeman; R L Magoffin; E H Lennette; R M Herndon
Journal:  Lancet       Date:  1967-07-15       Impact factor: 79.321

5.  Production of antibody by the central nervous system in subacute sclerosing panencephalitis.

Authors:  R W Cutler; E Merler; J P Hammerstad
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Studies of delayed dermal hypersensitivity in patients with subacute sclerosing panencephalitis.

Authors:  J T Jabbour; J A Roane; J L Sever
Journal:  Neurology       Date:  1969-10       Impact factor: 9.910

8.  Virus antibodies in subacute sclerosing panencephalitis: a study of 22 patients.

Authors:  N J Legg
Journal:  Br Med J       Date:  1967-08-05

9.  Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis.

Authors:  F E Payne; J V Baublis; H H Itabashi
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

10.  Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis.

Authors:  L Horta-Barbosa; D A Fuccillo; W T London; J T Jabbour; W Zeman; J L Sever
Journal:  Proc Soc Exp Biol Med       Date:  1969-10
View more
  3 in total

1.  Relationship between host age and persistence of Theiler's virus in the central nervous system of mice.

Authors:  C M Steiner; E J Rozhon; H L Lipton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

2.  Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

Authors:  S Haahr; A Møller-Larsen; E Pedersen
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 3.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.